Palomares R A, Hurley D J, Bittar J H J, Saliki J T, Woolums A R, Moliere F, Havenga L J, Norton N A, Clifton S J, Sigmund A B, Barber C E, Berger M L, Clark M J, Fratto M A
Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA 30602 United States; Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens GA 30602 United States.
Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA 30602 United States; Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens GA 30602 United States.
Vet Immunol Immunopathol. 2016 Oct 1;178:88-98. doi: 10.1016/j.vetimm.2016.07.003. Epub 2016 Jul 5.
Our objective was to evaluate the effect of an injectable trace mineral (ITM) supplement containing zinc, manganese, selenium, and copper on the humoral and cell mediated immune (CMI) responses to vaccine antigens in dairy calves receiving a modified-live viral (MLV) vaccine containing BVDV, BHV1, PI3V and BRSV. A total of 30 dairy calves (3.5 months of age) were administered a priming dose of the MLV vaccine containing BHV1, BVDV1 & 2, BRSV, PI3V, and an attenuated-live Mannheimia-Pasteurella bacterin subcutaneously (SQ). Calves were randomly assigned to 1 of 2 groups: (1) administration of ITM SQ (ITM, n=15) or (2) injection of sterile saline SQ (Control; n=15). Three weeks later, calves received a booster of the same vaccine combination SQ, and a second administration of ITM, or sterile saline, according to the treatment group. Blood samples were collected on days 0, 7, 14, 21, 28, 42, 56, and 90 post-vaccination for determination of antibody titer, viral recall antigen-induced IFN-γ production, and viral antigen-induced proliferation by peripheral blood mononuclear cells (PBMC). Administration of ITM concurrently with MLV vaccination resulted in higher antibody titers to BVDV1 on day 28 after priming vaccination compared to the control group (P=0.03). Calves treated with ITM showed an earlier enhancement in PBMC proliferation to BVDV1 following vaccination compared to the control group. Proliferation of PBMC after BVDV stimulation tended to be higher on day 14 after priming vaccination in calves treated with ITM than in the control group (P=0.08). Calves that received ITM showed higher PBMC proliferation to BRSV stimulation on day 7 after priming vaccination compared to the control group (P=0.01). Moreover, calves in the ITM group also had an enhanced production IFN-γ by PBMC after stimulation with BRSV on day 21 after priming vaccination compared to day 0 (P<0.01). In conclusion, administration of ITM concurrently with MLV vaccination in dairy calves resulted in increased antibody titer to BVDV1, and greater PBMC proliferation to BVDV1 and BRSV recall stimulation compared to the control group, suggesting that ITM might represent a promising tool to enhance the humoral and CMI responses to MLV vaccines in cattle.
我们的目标是评估一种含有锌、锰、硒和铜的可注射微量矿物质(ITM)补充剂,对接受含有牛病毒性腹泻病毒(BVDV)、牛疱疹病毒1型(BHV1)、副流感3型病毒(PI3V)和牛呼吸道合胞体病毒(BRSV)的改良活病毒(MLV)疫苗的犊牛体液免疫和细胞介导免疫(CMI)反应的影响。总共30头犊牛(3.5月龄)皮下注射(SQ)含有BHV1、BVDV1和2、BRSV、PI3V的MLV疫苗的初免剂量,以及减毒活曼氏杆菌-巴氏杆菌菌苗。犊牛被随机分为2组中的1组:(1)皮下注射ITM(ITM组,n = 15)或(2)皮下注射无菌生理盐水(对照组;n = 15)。三周后,犊牛根据治疗组接受相同疫苗组合的皮下加强免疫,以及第二次ITM或无菌生理盐水注射。在接种疫苗后的第0、7,、14、21、28、42、56和90天采集血样,以测定抗体滴度、病毒回忆抗原诱导的干扰素-γ产生,以及外周血单核细胞(PBMC)对病毒抗原诱导的增殖。与对照组相比,在初免疫苗接种后第28天,同时接种ITM和MLV疫苗的犊牛对BVDV1的抗体滴度更高(P = 0.03)。与对照组相比,接受ITM治疗的犊牛在接种疫苗后对BVDV1的PBMC增殖增强更早。在初免疫苗接种后第14天,接受ITM治疗的犊牛在BVDV刺激后PBMC的增殖倾向于高于对照组(P = 0.08)。与对照组相比,接受ITM的犊牛在初免疫苗接种后第7天对BRSV刺激的PBMC增殖更高(P = 0.01)。此外,与第0天相比,ITM组的犊牛在初免疫苗接种后第21天经BRSV刺激后PBMC产生的干扰素-γ也有所增强(P<0.01)。总之,与对照组相比,在犊牛中同时接种ITM和MLV疫苗可提高对BVDV1的抗体滴度,并增强PBMC对BVDV1和BRSV回忆刺激的增殖,这表明ITM可能是增强牛对MLV疫苗的体液免疫和CMI反应的一种有前景的工具。